Description
BSE demat auction settlement No. 791 listing securities available for auction across various scrips dated January 6, 2026.
Summary
BSE has published the demat auction list for Settlement No. 791 dated January 6, 2026. The auction includes 89 different scrips with varying quantities of securities available for auction settlement. This is a routine settlement mechanism for delivery obligations that could not be fulfilled through normal trading channels.
Key Points
- Settlement Number: 791
- Settlement Date: January 6, 2026
- Total scrips involved: 89
- Largest quantity: YES BANK LTD (233,250 shares)
- Other significant quantities: WELCURE DRUGS (50,000), WELSPUN SPEC (10,000), BIOGEN PHARMA (10,000), VANTAGE KNOWLEDGE (10,000)
- Includes major stocks like RELIANCE IND (50 shares), ITC LTD (99 shares), ADANI PORTS (20 shares)
- Smallest quantities: Single shares in several scrips including HCL TECH, ICICI BANK, IDBI BANK
Regulatory Changes
No regulatory changes. This is a routine operational circular.
Compliance Requirements
- Participants with outstanding delivery obligations in the listed scrips must participate in the demat auction settlement
- Securities must be delivered as per BSE auction settlement procedures
- Settlement obligations must be fulfilled as per the specified quantities
Important Dates
- Settlement Date: January 6, 2026
- Settlement No: 791
Impact Assessment
Low impact circular. This is a routine demat auction settlement that affects only specific participants with unfulfilled delivery obligations. The quantities involved are relatively small across most scrips, with the exception of YES BANK, WELCURE DRUGS, and a few others. This represents normal market settlement operations and does not indicate any systemic issues or broader market concerns.
Impact Justification
Routine demat auction settlement affecting limited quantities of shares across multiple scrips with no broader market implications